Board and Executive Management - Interpharma
About us

Board and Executive Management

Board

Jörg-Michael Rupp, Roche (President)

Katrien De Vos, AstraZeneca (Vicepresident)

Stefan Hendriks, Novartis (Vicepresident)

Leila Schwery, Johnson & Johnson (Vicepresident)


Sabine Bruckner, Pfizer

René P. Buholzer, Interpharma (Delegierter des Vorstands)

Graham Dorey, Biogen

Thorsten Hein, Bayer

Colleen Kamrad, GSK

Matthias Leuenberger, Novartis

Michael Lugez, BMS

Andrea Michael Meyer, Sanofi

Pierre Morneau, Takeda

Max Pahlow, Johnson & Johnson

Dan Staner, Moderna

Nathalie Stieger, F. Hoffmann-La Roche

Mads Stoustrup, Novo Nordisk

Employees

Executive management

Dr. René P. Buholzer

Managing director


Susanne Müller

Member of the Executive Board / Services


Markus A. Ziegler

Member of the Executive Board / Head of Markets


Yves Weidmann

Member of the Executive Board / Head of Governmental Affairs


Dr. Tanja Colin

Member of the Executive Board / Head of Approval & Technology


Simon Fry

Member of the Executive Board / Head of Innovation & IPR


Georg Därendinger

Member of the Executive Board / Head of Communication

+41 79 590 98 77

Media contacts

Michèle Sierro

Communication Manager Romandie

+41 79 305 84 30

Georg Därendinger

Member of the Executive Board / Head of Communication

+41 79 590 98 77

Board and Executive Management

Introducing Interpharma

read more

Annual report

Information on our key figures and activities in the financial year 2022

read more

Contact

Contact us

read more

Vision and Mission

More about the tasks and overriding aims of Interpharma

read more

Publications

Order and download publications.

read more